HDAC3 and liver cancer: Consistently, Lu et al21 have figured out that reduced HDAC3 inhibited xenograft tumour growth in liver cancer, and Cui et al22 have suggested that miR‐495‐3p contributed to restraining tumour growth in gastric cancer.